ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
Crinetics Pharmaceuticals Inc

Crinetics Pharmaceuticals Inc (CRNX)

46.81
2.38
(5.36%)
Closed March 29 04:00PM
46.81
0.00
(0.00%)
After Hours: 05:30PM

Unlock more advanced trading tools

Join ADVFN today

Key stats and details

Current Price
46.81
Bid
18.71
Ask
80.00
Volume
1,289,138
44.0101 Day's Range 47.16
15.23 52 Week Range 47.58
Market Cap
Previous Close
44.43
Open
44.52
Last Trade
10
@
46.81
Last Trade Time
Financial Volume
$ 58,706,532
VWAP
45.5394
Average Volume (3m)
756,847
Shares Outstanding
69,596,202
Dividend Yield
-
PE Ratio
-15.18
Earnings Per Share (EPS)
-3.08
Revenue
4.01M
Net Profit
-214.53M

About Crinetics Pharmaceuticals Inc

Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors.

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Headquarters
Wilmington, Delaware, USA
Founded
1970
Crinetics Pharmaceuticals Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker CRNX. The last closing price for Crinetics Pharmaceuticals was $44.43. Over the last year, Crinetics Pharmaceuticals shares have traded in a share price range of $ 15.23 to $ 47.58.

Crinetics Pharmaceuticals currently has 69,596,202 shares outstanding. The market capitalization of Crinetics Pharmaceuticals is $3.26 billion. Crinetics Pharmaceuticals has a price to earnings ratio (PE ratio) of -15.18.

CRNX Latest News

Form 4 - Statement of changes in beneficial ownership of securities

="/apology_objects/ecms/images/photoStreamIcon.png">SEC Photostream View All Social Media SEC.gov Search Form Search SEC.gov Company Filings | More Search...

Form 4 - Statement of changes in beneficial ownership of securities

SEC Form 4 FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIPFiled pursuant to Section 16(a) of the Securities Exchange...

Form 4 - Statement of changes in beneficial ownership of securities

SEC Form 4 FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIPFiled pursuant to Section 16(a) of the Securities Exchange...

Form 4 - Statement of changes in beneficial ownership of securities

SEC Form 4 FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIPFiled pursuant to Section 16(a) of the Securities Exchange...

Form 4 - Statement of changes in beneficial ownership of securities

SEC Form 4 FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIPFiled pursuant to Section 16(a) of the Securities Exchange...

Form 4 - Statement of changes in beneficial ownership of securities

SEC Form 4 FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIPFiled pursuant to Section 16(a) of the Securities Exchange...

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments

As filed with the Securities and Exchange Commission on March 1, 2024 Registration No. 333-277484 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.952.0715220235545.8647.1642.3371356344.11370735CS
41.723.8145930361545.0947.5837.4492278042.84541878CS
1211.5932.907438955135.2247.5833.6775684739.84068762CS
2618.6165.992907801428.247.5825.3583777834.76083469CS
5231.05197.01776649715.7647.5815.2386997229.0158898CS
15631.11198.15286624215.747.5814.8447738225.53644574CS
26024.31108.04444444422.547.5810.6332955824.40362631CS

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
AVTXAvalo Therapeutics Inc
$ 22.08
(364.84%)
31.9M
NXLNexalin Technologies Inc
$ 1.50
(92.31%)
11.67M
CEROCERo Therapeutics Holdings Inc
$ 3.112
(90.92%)
24.08M
BDRXBiodexa Pharmaceuticals PLC
$ 1.6201
(88.60%)
88.37M
KYCHKeyarch Acquisition Corporation
$ 12.30
(75.58%)
196.62k
BOLDBoundless Bio Inc
 14.25
(-76.24%)
767.63k
PMECPrimech Holdings Ltd
$ 1.2999
(-66.50%)
8.28M
TNXPTonix Pharmaceuticals Holding Corporation
$ 0.1816
(-44.45%)
21.92M
GMDAGamida Cell Ltd
$ 0.036
(-39.19%)
89.18M
NBSTWNewbury Street Acquisition Corporation
$ 0.042279
(-38.28%)
1.75k
NKLANikola Corporation
$ 1.035
(13.85%)
163.84M
GMDAGamida Cell Ltd
$ 0.036
(-39.19%)
89.18M
BDRXBiodexa Pharmaceuticals PLC
$ 1.6201
(88.60%)
88.37M
MARAMarathon Digital Holdings Inc
$ 22.56
(2.22%)
86.14M
AKANAkanda Corporation
$ 0.1166
(-29.29%)
80.34M

Your Recent History

Delayed Upgrade Clock